1. Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience. (3rd July 2018) Authors: Ikram, Asad; Donnelly, Joseph P.; Sperry, Brett W.; Samaras, Christy; Valent, Jason; Hanna, Mazen Journal: Amyloid Issue: Volume 25:Number 3(2018) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment of relapsed multiple myeloma: Evidence-based recommendations. (January 2020) Authors: Durer, Ceren; Durer, Seren; Lee, Sarah; Chakraborty, Rajshekhar; Malik, Mustafa Nadeem; Rafae, Abdul; Zar, Muhammad Abu; Kamal, Ahmad; Rosko, Nathaniel; Samaras, Christy; Valent, Jason; Chaulagain, Chakra; Anwer, Faiz Journal: Blood reviews Issue: Volume 39(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Progression with clinical features is associated with worse subsequent survival in multiple myeloma. Issue 4 (6th February 2019) Authors: Chakraborty, Rajshekhar; Liu, Hien D.; Rybicki, Lisa; Tomer, Jacqulyn; Khouri, Jack; Dean, Robert M.; Faiman, Beth M.; Kalaycio, Matt; Samaras, Christy J.; Majhail, Navneet S.; Valent, Jason Journal: American journal of hematology Issue: Volume 94:Issue 4(2019:Apr.) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. Issue 6 (30th March 2022) Authors: Sanchorawala, Vaishali; Palladini, Giovanni; Minnema, Monique C.; Jaccard, Arnaud; Lee, Hans C.; Gibbs, Simon; Mollee, Peter; Venner, Christopher; Lu, Jin; Schönland, Stefan; Gatt, Moshe; Suzuki, Kenshi; Kim, Kihyun; Cibeira, María Teresa; Beksac, Meral; Libby, Edward; Valent, Jason; Hungria, Van... Journal: American journal of hematology Issue: Volume 97:Issue 6(2022) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia). (19th January 2022) Authors: Bou Zerdan, Maroun; Valent, Jason; Diacovo, Maria Julia; Theil, Karl; Chaulagain, Chakra P. Other Names: Kumar Shaji Academic Editor. Journal: Advances in hematology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma. Issue 3 (11th March 2020) Authors: Chari, Ajai; Cornell, Robert F.; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V.; Niesvizky, Ruben; Lunning, Matthew; Usmani, Saad Z.; Anderson, Larry D.; Chhabra, Saurabh; Girnius, Saulius; Shustik, Chaim; Stuart, Robert; Lee, Yihua; Salman, Zeena; Liu, Emily; Valent, Jason Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients. (August 2022) Authors: Rafae, Abdul; Ehsan, Hamid; Wahab, Ahsan; Khan, Sana Irfan; Khan, Israr; Ashraf, Sara; Ali, Sundas; Khalid, Farhan; Neupane, Karun; Valent, Jason; Khouri, Jack; Samaras, Christy; Mazzoni, Sandra; Anwer, Faiz Journal: Critical reviews in oncology/hematology Issue: Volume 176(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. (28th February 2020) Authors: Chakraborty, Rajshekhar; Rybicki, Lisa; Nakashima, Megan O.; Dean, Robert M.; Faiman, Beth M.; Samaras, Christy J.; Rosko, Nathaniel; Dysert, Hayley; Valent, Jason; Anwer, Faiz Journal: British journal of haematology Issue: Volume 189:Number 6(2020) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma. (3rd February 2020) Authors: Basali, Diana; Chakraborty, Rajshekhar; Rybicki, Lisa; Rosko, Nathaniel; Reed, Janice; Karam, Maryann; Schlueter, Kristen; Dysert, Hayley; Kalaycio, Matt; Valent, Jason Journal: British journal of haematology Issue: Volume 189:Number 6(2020) Page Start: 1136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study. (17th May 2021) Authors: Covut, Fahrettin; Ahmed, Ramsha; Chawla, Sanchit; Ricaurte, Frank; Samaras, Christy J.; Anwer, Faiz; Garcia, Alex V. M.; Angelini, Dana E.; Mazzoni, Sandra; Faiman, Beth; Valent, Jason; Khouri, Jack Journal: British journal of haematology Issue: Volume 193:Number 6(2021) Page Start: 1213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗